Cleared Special

K251007 - CrossWise RF Transseptal Access System (Models: CW-1085S, CW-1085A, CW-1012W, CW-1012C, CW-1085C, CW-1085V, CW-1013F) (FDA 510(k) Clearance)

May 2025
Decision
30d
Days
Class 2
Risk

K251007 is an FDA 510(k) clearance for the CrossWise RF Transseptal Access System (Models: CW-1085S, CW-1085A, CW-1012W, CW-1012C, CW-1085C, CW-1085V, CW-1013F). This device is classified as a Catheter, Septostomy (Class II - Special Controls, product code DXF).

Submitted by Circa Scientific, Inc. (Englewood, US). The FDA issued a Cleared decision on May 1, 2025, 30 days after receiving the submission on April 1, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.5175.

Submission Details

510(k) Number K251007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2025
Decision Date May 01, 2025
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DXF - Catheter, Septostomy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.5175